Name
PUBLIC HEALTH PARALLEL 5 - Hepatitis B, C, D elimination
Date & Time
Thursday, March 20, 2025, 1:30 PM - 3:00 PM
Speakers
Jennifer Havens, University of Kentucky
Jana Manning, The Task Force for Global Health: CGHE
Natasha Martin, UCSD
Homie Razavi, Center for Disease Analysis Foundation
Tawesak Tanwandee, Siriraj Hospital/Mahidol University
Peter Vickermn, University of Bristol
Jana Manning, The Task Force for Global Health: CGHE
Natasha Martin, UCSD
Homie Razavi, Center for Disease Analysis Foundation
Tawesak Tanwandee, Siriraj Hospital/Mahidol University
Peter Vickermn, University of Bristol
Description
- Novel Interventions to Facilitate Hep C Elimination in Rural Settings (Integrating work on larger scale, randomized control trials, rural home test kits) Jennifer Havens
- Addressing Barriers to Hepatitis B Screening in Low and Middle Income Settings Tanwandee Tawasek
- Oral Presentation: MODELING HEPATITIS C VIRUS ELIMINATION IN THE UNITED STATES: ARE WE ON TRACK TO REACH INCIDENCE TARGETS? Natasha Martin
PROGRESS TOWARD HEPATITIS C ELIMINATION IN HIGH-INCOME COUNTRIES Homie Razavi - Oral Presentation: A COMPARATIVE ANALYSIS OF NATIONAL HBV ELIMINATION POLICIES, PROGRAMS, AND PROGRESS ACROSS INCOME LEVELS Jana Manning
- Oral Presentation: MODELLING THE IMPACT AND COST-EFFECTIVENESS OF SCALING UP OF HCV CASE FINDING AND TREATMENT FOR ACHIEVING ELIMINATION AMONG PEOPLE WHO INJECT DRUGS IN ENGLAND Peter Vickerman
- Q&A